| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $77K | -74.8% |
| Cost of Revenue | $82K | -61.0% |
| R&D Expense | $14.7M | -3.3% |
| SG&A Expense | $16.1M | -1.3% |
| Operating Income | -$36.6M | +8.0% |
| Interest Expense | $28K | -49.1% |
| Income Tax | $0 | — |
| Net Income | -$32.9M | +9.2% |
| EPS (Basic) | -$0.99 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.0M | +4.2% |
| Short-term Investments | $42.2M | -6.7% |
| Accounts Receivable | $34K | -78.8% |
| Current Assets | $47.6M | -22.4% |
| Total Assets | $72.6M | -24.0% |
| Current Liabilities | $24.8M | +1.3% |
| Total Liabilities | $24.8M | -2.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.2M | +47.8% |
| Capital Expenditures | $56K | -56.3% |
| Investing Cash Flow | $11.7M | +2581.1% |
| Financing Cash Flow | $2.6M | +246.9% |
| Free Cash Flow | -$14.2M | +47.9% |
| +14.7% |
| EPS (Diluted) | -$0.99 | +14.7% |
| Stockholders' Equity |
| $47.8M |
| -31.9% |